Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy
- 21 November 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (49), 19569-19574
- https://doi.org/10.1073/pnas.1115484108
Abstract
The mechanism of action of 2-hydroxyoleic acid (2OHOA), a potent antitumor compound, has not yet been fully elucidated. Here, we show that human cancer cells have markedly lower levels of sphingomyelin (SM) than nontumor (MRC-5) cells. In this context, 2OHOA treatment strongly augments SM mass (4.6-fold), restoring the levels found in MRC-5 cells, while a loss of phosphatidylethanolamine and phosphatidylcholine is observed (57 and 30%, respectively). The increased SM mass was due to a rapid and highly specific activation of SM synthases (SMS). This effect appeared to be specific against cancer cells as it did not affect nontumor MRC-5 cells. Therefore, low SM levels are associated with the tumorigenic transformation that produces cancer cells. SM accumulation occurred at the plasma membrane and caused an increase in membrane global order and lipid raft packing in model membranes. These modifications would account for the observed alteration by 2OHOA in the localization of proteins involved in cell apoptosis (Fas receptor) or differentiation (Ras). Importantly, SMS inhibition by D609 diminished 2OHOA effect on cell cycle. Therefore, we propose that the regulation of SMS activity in tumor cells is a critical upstream event in 2OHOA antitumor mechanism, which also explains its specificity for cancer cells, its potency, and the lack of undesired side effects. Finally, the specific activation of SMS explains the ability of this compound to trigger cell cycle arrest, cell differentiation, and autophagy or apoptosis in cancer cells.Keywords
This publication has 34 references indexed in Scilit:
- The RB-E2F1 Pathway Regulates AutophagyCancer Research, 2010
- Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipidsFEBS Letters, 2009
- Antiapoptotic roles of ceramide‐synthase‐6‐generated C16‐ceramideviaselective regulation of the ATF6/ CHOP arm of ER‐stress‐response pathwaysThe FASEB Journal, 2009
- Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acidProceedings of the National Academy of Sciences of the United States of America, 2009
- The sphingolipid salvage pathway in ceramide metabolism and signalingCellular Signalling, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosisJournal of Lipid Research, 2008
- Sphingomyelin synthase 1 suppresses ceramide production and apoptosis post-photodamageBiochemical and Biophysical Research Communications, 2007
- Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid raftsBiochemical Journal, 2006
- Fatty acid incorporation is decreased in astrocytes cultured from α‐synuclein gene‐ablated miceJournal of Neurochemistry, 2005